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ABSTRACT 
Healthcare expenses will be the most relevant policy issue for most governments in the EU 
and in the USA. This expenditure can be associated with two major key categories: 
demographic and economic drivers. Factors driving healthcare expenditure were rarely 
recognised, measured and comprehended. An improvement of health data generation and 
analysis is mandatory, and to tackle healthcare spending growth, it may be useful to design 
and implement an effective, advanced system to generate and analyse these data. A 
methodological approach relied upon the HDE can be a suitable option. By definition, in 
the HDE a large amount of data sets having several sources are functionally interconnected 
and computed through learning machines that generate patterns of highly probable future 
health conditions of a population. Entanglement concept is borrowed from quantum physics 
and means that multiple particles (information) are linked together in a way such that the 
measurement of one particle's quantum state (individual health conditions and related 
economic requirements) determines the possible quantum states of other particles 
(population health forecasts to predict their impact). The value created by the HDE is based 
on the combined evaluation of clinical, economic and social effects generated by health 
interventions. To predict the future health conditions of a population, analyses of data are 
performed using self-learning artificial intelligence (AI), in which sequential decisions are 
based on Bayesian algorithmic probabilities. HDE and AI-based analysis can be adopted to 
improve the effectiveness of the health governance system in ways that also lead to better 
quality of care. 
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INTRODUCTION  
Although many countries are currently trying to constrain or stabilize it, over the last two 
decades healthcare spending has been rising faster than the national GDP itself [1-3]. 
Looking towards the future, according to a medium and long-term perspective, healthcare 
expense will be one of the most relevant policy issues for most governments in the EU and 
the USA [4]. Although the growth has not been perfectly linear (indeed, economy and 
healthcare spending commonly grow at different rates), the share of the economy spent on 
healthcare in the USA [5] has quadrupled in 2009 compared to 1929. During the recession 
in 2008, the GDP growth was depressed concededly, but healthcare spending growth was 
not nearly as dampened. The concerns raised by projections are not simply academic: they 
have a real impact upon the wellbeing of the citizens and hence, upon the economy of 
nations.   
In this article two critical issues are investigated: the growth of healthcare spending 
(including possible influencing factors); also, an advanced system to evaluate and tackle 
healthcare spending growth, which is actually a brand new methodology designed to 
improve the effectiveness of national health services. Hence, this paper is neither a 
systematic literature review nor an assessment of new studies. Rather, the aim of the current 
speculative research is to report the authors' opinions about basic principles and advanced 
future procedures that will help public health authorities make proper decisions and achieve 
national health goals. 
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THE GROWTH OF HEALTHCARE SPENDING 
Despite the inevitable uncertainty surrounding cause-effect relationships, the public 
healthcare expenditure is associated with two major key categories: demographic and non-
demographic (economic) drivers (figure 1) [4]. Demographic drivers are directly correlated 
with the dynamic variations of population structure (basically the ageing process of a 
population). Over the next years, in all countries a continuous increase in age will be 
observed, leading to unprecedented shares of the population being 70-80 years and older. 
The greater the life expectations, the higher the demand for healthcare for a population, 
especially in elderly people with probable cognitive impairment and other chronic 
disabilities [6]. This will have a further impact on social security as well as social and 
healthcare spending. However, the ageing of the population cannot explain the whole story. 
The relationship between health expense and income is still a controversial issue [4]. 
Indeed, independently of the precise income elasticity, the combined effect of demographic 
variations and income do not provide a comprehensive explanation for the health spending 
growth. 
Some obvious factors can be mentioned: social preferences, public health standards, 
subsidy systems, taxation systems. Although the equation describing this association is not 
conclusive, some basic factors such as technological advancement, health policy decisions 
(i.e. access requirements and procedures) and prices are the most likely predictors for 
explaining the relationship between healthcare spending and income [4]. Moreover, 
considering the deterioration in today’s economic environment, it’s worth mentioning the 
potential relationship between determinants of contribution to GDP and consumption of 
economic resources due to healthcare demand (figure 2). While economic determinants 
may produce different GDP results with a remarkable level of uncertainty, healthcare needs 
seem to be more easily predictable in consuming these resources (when suitable data exist, 
of course). Clear and comprehensive disclosures of uncertainties concerning GDP growth 
rate and, most importantly, the collection and analysis of that data driving an expected 
future risk to consume an increasing amount of healthcare resources are critical in this 
situation. The wise use of healthcare resources becomes a significant issue: in the future the 
GPD growth rate will be much less likely to result in higher living standards (quality of life 
or quality of services delivered). The burden of supporting an ageing society and the 
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expanding cost of healthcare will take out a large proportion of workers’ productivity 
improvements for years to come.   
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HEALTH DATA AND THE ECONOMIC ASSESSMENT OF HEALTH 
INTERVENTIONS 
The availability of new highly targeted drugs and advanced health technologies produced 
insurmountable improvements in terms of health units gained worldwide, with a 
consequent average increase of life expectancy [7]. However, the majority of advances in 
medical technology comes at higher prices compared with the current ones [8]. As a result, 
new costs must be added to the healthcare funding for previously unavailable diagnostic 
procedures and treatments. So, in this turbulent economic time, health authorities and other 
bodies are increasingly requiring economic and clinical evidences as cost analysis and cost 
containment are becoming a central issue in each healthcare system. Nowadays, economic 
evaluations are routinely used in many countries to assess new health technologies and 
make decisions on pricing and reimbursement. The overall economic assessment should 
lead to a powerful enhancement in the quality of healthcare services delivered.  
The cost-effectiveness and the economic sustainability of health interventions are 
commonly measured by means of parameters such as the cost per QALY gained, whose 
values should be included in a range of predetermined thresholds. QALY is used by major 
regulatory agencies (i.e. FDA, EMA, NICE) as an integral part of health technology 
assessment methods and procedures [9]. Unfortunately, social costs are not systematically 
taken into account by regulatory agencies, even during the assessment of reimbursement 
procedure for new costly health technologies. Naturally, it can be argued that since utilities 
attributed to the recovery or preservation of a healthy state are closely related to a specific 
population [10, 11], values of QALY gained can be different between countries and hence 
international comparisons are not always performed or actually usable. However, the 
collection of data having a great impact like indirect costs (i.e. social security spending and 
the productivity lost due to absenteeism) cannot be neglected, especially in this moment. 
First of all, the reduction of absenteeism at the workplace can improve or recover the 
productivity and the contribution to the GDP growth rate. Second, a decline of 
presenteeism (a hidden measure of lost productivity due to workers' being on the job but 
not fully performing because of illness or other medical conditions), can generate an 
optimization of production and/or service costs. As a consequence, the quality of 
workforce’s life and above all the industry's competitiveness profile can be substantially 
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enhanced. An effective strategic advantage in a sluggish economy, especially bearing in 
mind that presenteeism may actually be a much costlier problem than absenteeism 
(approximately 3-10 times higher) [12, 13]. Moreover, it’s worth mentioning that 
presenteeism is quite common in tough economic times, when employees may be 
extremely afraid of losing their jobs.  
At present time, there are several sources of health data: observational studies, claims 
databases, registries, PRO and other medical record linkage systems which can show 
different reliability and controversial degree of credibility from the regulatory agencies' 
perspective [14]. Despite plenty of health data, a majority of them commonly show some 
caveats [15, 16] that may affect the credibility of some health assessment procedures (table 
1).   
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HEALTH DATA ENTANGLEMENT AND ARTIFICIAL INTELLIGENCE-BASED 
ANALYSIS 
In several health databases, important pieces of information are still missing. As a result, 
available surrogate information cannot effectively inform probabilistic models used for 
better strategic decision making. The uncertainty associated with these data may undermine 
the effectiveness of any decision in public health governance. An improvement of health 
data generation and analysis is mandatory. Even in countries with a remarkable GDP 
growth rate like the United Arab Emirates, a recent study revealed that several health issues 
deserve to be accurately addressed [17]. As an emerging suggestion, authors reported that 
reliable and valid longitudinal data must be considered as essential for planning population-
based health programmes [17]. 
The increase of healthcare budgets in response to growing demand without its assessment 
and governance is no longer a viable option. Despite its magnitude in the overall economy, 
the key elements that drive healthcare expenditure have been rarely recognized, measured 
and comprehended. Therefore, to tackle healthcare spending growth, the design and 
implementation of an effective, advanced system to generate and analyze real and qualified 
health data may be advised. This system should allow the achievement of the following 
aims: a) measure the economic effectiveness of the current health policy procedures; b) 
estimate the value of health governance decisions and calculate the proper health funding; 
c) identify priorities and guide the implementation of corrective policies in order to 
improve the overall health of a population with an economically sustainable use of 
resources. To this purpose, the methodological approach relied upon the HDE seems to be a 
suitable option. This approach is based on a multifaceted mix of technology, statistics, 
computer science, and medical knowledge. By definition, in the HDE a large amount of 
data sets having several sources are functionally interconnected and computed through 
learning machines that generate patterns of highly probable future health conditions of a 
population.     
Entanglement concept is borrowed from quantum physics and refers to the presence of 
correlations (i.e. inseparable interconnections) between observable physical quantities (in 
this case, wide health variables that are not necessarily resident or generated in the same 
place). Briefly, quantum entanglement means that multiple particles (or information) are 
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linked together in a way such that the measurement of one particle's quantum state (in our 
more modest context, individual health conditions and related economic requirements) 
determines the possible quantum states of other particles (i.e. population health forecasts 
exploited to predict the overall economic impact and drive policy decisions). The value 
created by the HDE is based on a wider and more combined evaluation of clinical, 
economic and social effects generated by health interventions. Such an assessment is 
performed according to a predictive analytics approach (several interconnected variables 
can be considered). A comprehensive appraisal of clinical value, economic value, social 
value and system of governance value of health interventions is carried out per each 
beneficiary and patient subpopulations (figure 3). As a result of these specific analyses, 
public health decisions are data-driven and resources can be effectively used. Data can be 
generated, collected and stored by the means of several technological systems [including 
innovative smart devices (i.e. watches and phones) advanced web technologies, electronic 
cards, remote patient management such as telemedicine and telecare, or biosensors]. The 
remote patient monitoring is already more than a promising cost-effective tool to help 
deliver sweeping improvements in healthcare [18]. Indeed, the innovative healthcare 
services delivered this way is supposed to reduce disease management programme costs 
while preserving, but it is much more likely to enhance, the quality of care provided. 
Beyond the fact that the entanglement approach provides a unique interconnection of 
qualified data to support health decisions, it is worth noting that analysis of data is 
performed using «self-learning AI», in which sequential decisions are based on Bayesian 
algorithmic probabilities. The approach is based on a direct approximation of a cybernetic 
system called an AIXI 1  agent. AIXI can be seen as a mathematical definition of AI. 
According to M. Hutter [19], AIXI is the most intelligent unbiased agent possible, used to 
formally solve a number of problem classes, including sequence prediction, strategic 
games, function minimization, reinforcement and supervised learning. Apparently, the 
major limit of the AIXI model is that it can be incomputable. To overcome this problem, 
Hutter developed a modified algorithm AIXItl, which is still effectively more intelligent 
                                                          
1 AIXI or super artificial intelligence is basically a simple concept. It combines a search strategy over all 
possible futures of an agent (a math operator using observations, rewards and actions) with a weight that 
favours thriftiness (in the sense of the complexity of a programme reaching this future, its sequence of actions 
and observations). 
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than any other time 𝑡 and space 𝑙 bounded agent [20]. Whether U(𝑞, 𝑎1𝑎2 … 𝑎𝑛) denotes 
the output of a universal machine 𝑈, informed by programme 𝑞 and input (𝑎1𝑎2 … 𝑎𝑛), 
𝑚 ∈ 𝑁  is a finite look ahead at the horizon, and 𝑙(𝑞) is in the amount of bits in the 
programme 𝑞, once the cybernetic agent has picked the actions (𝑎1𝑎2 … 𝑎𝑡−1) and received 
the sequence of observations-reward pairs 𝑜1𝑟1𝑜2𝑟2  … 𝑜𝑡−1𝑟𝑡−1  from the environment, 
AIXI is equal to (1) [21]: 
 
𝑎𝑡 
∗ = arg max
𝑎𝑡
 ∑ … max
𝑎𝑡+𝑚𝑜𝑡𝑟𝑡
 ∑ [𝑟𝑡 + ⋯ 𝑟𝑡+𝑚]
𝑜𝑡+𝑚𝑟𝑡+𝑚
 ∑ 2−𝑙(𝑞)
𝑞:𝑈(𝑞,𝑎1… 𝑎𝑡+𝑚)= 𝑜1𝑟1… 𝑜𝑡+𝑚𝑟𝑡+𝑚
 
   
 
 
Therefore, according to equation (1), AIXI considers the amount of the total rewards over 
all possible futures up to 𝑚  steps ahead, weighs each of them by the complexity of 
programmes consistently with data collected in the past, and then picks the action that 
maximises expected future rewards. Assuming that the agent does not initially know the 
true environment (healthcare data must be progressively collected), it is suggested the 
development of models whose predictive performance improves as the agent gains 
experience. A way to provide such a model is to take into account the Bayesian perspective. 
According to Veness et al. [21], instead of committing to any single fixed environment 
model, the cybernetic agent uses a mixture of environment models. This implies a model 
class (a class of possible environments), the designation of an initial weight to each 
possible environment (the prior), and finally the updating of the weight for each model 
(computing the posterior) each time more experience is obtained. So, given a countable 
model class 𝑀: =  {𝜌1, 𝜌2, … }  and a prior weight 𝑤0
𝜌
> 0  for each 𝜌 ∈ 𝑀  such that 
∑ 𝑤0
𝜌
= 1𝜌∈𝑀 , the mixture environment model is given by (2):  
 
ξ(x1:n|a1:n): = ∑ 𝑤0
𝜌
𝜌∈𝑀
𝜌(𝑥1:𝑛|𝑎1:𝑛) 
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Hence, considering equation (1), the universal Bayesian agent can be formally expressed 
as: 
𝑎𝑡 
∗ = arg max
𝑎𝑡
 ∑ … max
𝑎𝑡+𝑚𝑜𝑡𝑟𝑡
 ∑ [𝑟𝑡 + ⋯ 𝑟𝑡+𝑚]
𝑜𝑡+𝑚𝑟𝑡+𝑚
 ∑ 2𝐾(𝜌)
𝜌∈𝑀
 𝜌(𝑥1:𝑡+𝑚|𝑎1:𝑡+𝑚) 
 
where 𝜌(𝑥1:𝑡+𝑚|𝑎1:𝑡+𝑚)  is the probability of observing 𝑥1, 𝑥2 ⋯ 𝑥𝑡+𝑚  given actions 
𝑎1, 𝑎2 ⋯ 𝑎𝑡+𝑚; class 𝑀𝑈consists of all enumerable chronological semimeasures [19], which 
includes all computable 𝜌; and 𝐾(𝜌) denotes the Kolmogorov complexity [22] of 𝜌 with 
respect to 𝑈. 
The direct AIXI approximation is a Bayesian optimality notion for universal reinforcement 
learning agents in unknown or partially known environments [19]. Reinforcement learning 
is a general and influential paradigm for agents that learn from experience [23]. According 
to J.S. Albus [24] the AI can be defined as « . . . the ability of a system to act appropriately 
in an uncertain environment, where appropriate action is that which increases the 
probability of success, and success is the achievement of behavioural subgoals that support 
the system’s ultimate goal.» Therefore, to find out proper corrective actions and achieve a 
better health governance system, a Bayesian approach and Monte Carlo simulations must 
be included as a part of an AI self-learning cycle (figure 4) [21]. The AIXI agent interacts 
with the environment (i.e. healthcare setting) in cycles. In each cycle, the agent executes an 
action and in turn receives observations and rewards. The only information available to the 
agent is the history of previous interactions (analysis of data previously generated and 
stored). The basic reinforcement learning problem is to build up an agent that collects as 
much reward as possible (expected positive futures) from a partial known environment over 
time [21]. In other words, a sequence of phases called learning (in which future 
observations and rewards are predicted on the basis of past experiences), and planning 
(where the best future actions are determined and possibly implemented). The use of AI in 
health governance decisions is certainly a compelling application, and some university 
research centres are implementing this brilliant and effective application in healthcare 
setting [25, 26].  
There is a further issue that deserves to be analyzed: why this approach should be adopted. 
The HDE and AI-based assessment provide an unprecedented world of information. First of 
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all, this approach allows one to produce scenarios and forecasts concerning the effect of 
policy decisions on the health conditions of a population definitively and more accurately 
than anything else at the present; this is because it may consider the effect of many more 
variables (accurately measured) at the same time. No other system can claim to produce 
similar results. Large databases can provide interesting answers and uncover several 
potential factors influencing outcomes in the disease management of a given condition. 
However, there are also many biases associated with large databases and as a consequence 
a lot of uncertainty can be seen. This is basically due to the fact that one person's data 
usually are in different places [15]. Additional key players in generating biases are factors 
driving the collection, coding, and preservation of the data; the extensive customization of 
different systems that collect similar data; the fragmentation of the healthcare delivery 
system and its records; and finally, privacy and proprietary considerations [15]. When we 
have to deal with huge amounts of information that are not specifically coupled to each 
other and/or not univocally related with individual patients, one can only piece together 
some pattern and on this basis make relatively reliable predictions of the future. That's why 
we wonder whether medicine can learn anything from the current experiences of Amazon 
or Netflix. They can make interesting customer profiles, improve strategic business 
decisions, allowing faster decision-making processes, and ultimately gain a competitive 
advantage. However, big databases (especially those relative to health) offer several 
technical and technological challenges. Due to its massive volume (from terabytes to 
exabytes), complexity and unstructured nature, big databases require advanced data storage, 
extremely high computational performance, as well as analysis and visualization techniques 
[27]. Indeed, there still remain concerns that the statistical results for this observational data 
analysis may not be revealing valid causal pathways [28]. In order to analyse big databases, 
some authors believe that familiar statistical approaches cannot be applied and therefore, 
analysts should explore new methods and techniques [29]. So, at the moment, how is it 
possible to make proper health policy decisions and allocate economic resources to face the 
future health conditions of a population using big health databases?  
The HDE provides an in-depth portrait of the national health condition performing a unique 
combination of macrodata (economic and social assessment) with micro or nanodata 
(clinical analysis). Actually, health-related data typically consist of information generated 
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by various entities such as healthcare providers, healthcare encounters, social security, 
insurance companies and so on. Hence, the core of information commonly shows a set of 
attributes. All health-related data sources must be unequivocally associated and harmonized 
by bringing different data sets together. If there is a unique identifier (achieved by the 
means of smart devices, web technologies, health insurance electronic cards, biosensors or 
other) available for virtually all the individuals, then it is possible to have qualified data to 
perform a perfect data entanglement. When data elements are entangled, they can be 
considered as inferentially equivalent, and can thus be compared and used meaningfully in 
statistical analysis or even better processed with AI. The entanglement procedure therefore 
enables data integration; an approach that should be implemented for different scopes, 
including the necessity to obtain an economic assessment of resources used or to allocate 
the appropriate healthcare funding, and finally to investigate relatively rare events (i.e. 
orphan diseases). As a first step, the combination of macrodata is achieved considering 
individual and subpopulation data, then the AI predicts the key features of future 
conditions, health needs, funding, and proper policy resolutions to maintain and improve 
the health status of the population. With the HDE, fine-grained targeted data (namely 
nanodata - multiple daily measurements of blood pressure or glucose blood test are 
common examples) can be collected, allowing the understanding of individual patient needs 
(as well as patient population needs) and make appropriate decisions in healthcare 
management. This also gives the chance to use these data to inform comprehensive 
probabilistic models. Indeed, the full integration of fine-grained data and the use of the AI 
allow the identification of the most appropriate, effective and specific solutions pertaining 
to the given context. These health governance solutions take into account the evolution of 
health conditions, distinctively predicted in that population. The historical health data 
gathered with the HDE are more complete compared with the currently available systems. 
This is also true when a potential comparison with a large set of health data (the so called 
big databases) is considered. Indeed, the nature itself of the healthcare industry contributes 
to limit the usefulness and potential feasibility of big databases. The sharing of data among 
different functions and players is crucial, and creates challenges as well; so, important 
pieces of information often remain overlooked due to an organizations lack of procedures 
for the full integration of data.  
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Outputs and solutions that come from the HDE implementation can be grouped in major 
clusters as reported in table 2 (see also figure 3). Estimates produced with this new system 
are different and have nothing to do with findings derived from health economic methods. 
The level of uncertainty surrounding outputs (futures) is expected to be extremely low or 
virtually removed. When machine learning is considered, the environment is commonly 
simulated with Markov decision process (sometimes with Bayesian networks) since 
reinforcement learning algorithms use dynamic techniques. The most relevant difference 
between the conventional techniques and the HDE (reinforcement learning algorithms or 
AIXI) is that the latter does not need knowledge and can always be utilized, even when 
other methods (such as the above mentioned) requiring exact or formally correct 
information (often missing) become infeasible [30]. Naturally, some techniques such as 
cost effectiveness or cost utility analysis will continue to have their role in economic 
assessment; especially, when a new health intervention must be evaluated. Initially, 
conventional methodologies of economic assessment and HDE would be considered 
complementary since some outputs of HDE can be used to inform probabilistic economic 
models. Since the generation of individual health data is a time-dependent process, while 
the HDE is in its early stage, some data will be drawn from different sources having their 
own diversity, complexity and timeframe. A sort of supplementary approach dedicated to 
assimilating knowledge from biomedical data. Over time, the more HDE is used, the more 
specific and well-structured health information will be generated and available for self-
learning AI analyses. 
At the present, as far as we know, no other system should be capable of indicating with a 
comparable accuracy how to establish priorities (ex-ante assessment) and consequences 
(ex-post assessment) of health policy decisions. The HDE and the AI-based assessment are 
a unique tool because they are used to protect the health of the population (considering the 
demographic dynamics and epidemiology of the most important diseases), and the wellness 
of citizens (probably through a contribution in the achievement of the expected GDP 
growth).  
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HEALTH DATA PROTECTION 
Since the collection of sensitive health data and personal information are captured, the 
implementation of all requirements to assure data protection is absolutely mandatory and it 
must be taken into account in advance. Naturally, the patient’s right to personal data 
privacy and the possibility to perform scientific research should be considered and 
balanced. Anonymisation of patient records, informed patient consent and data aggregating 
can be considered like fundamental rules to respect the patient’s basic right to privacy. In 
recent years, privacy and security procedures have been evolving to keep up with the 
remarkable changes induced by the technological evolution. In the USA, health authorities 
modified some privacy and security rules associated with the electronic transmission of 
health information introducing the Health Information Technology for Economic and 
Clinical Health Act in 2009 [31].  
In 2012, the EU released an updated version of the European General Data Protection 
Regulation [32] in which privacy and security requirements have been significantly 
strengthened compared to previous documents published in 1995 [33]. Indeed, in order to 
produce innovations that are important for public health and useful in practice, research has 
to comply with generally accepted ethical, legal and administrative principles. The HDE is 
based on an advanced method evaluating large amounts of patient information. Therefore, 
its implementation would obviously need to also comply with data protection legislation, 
particularly in relation to access to and the safekeeping of the data. However, an additional 
peculiarity of the HDE approach is that the data storage system can be entangled as well. 
From an information technology perspective, data entanglement was initially suggested as a 
mechanism for increasing censorship resistance in document-storage systems [34, 35]. Now 
entanglement is used to protect the data from an untrusted storage provider that might be 
tempted to damage or destroy the data through negligence or malice [36]. When two files 
are entangled they are somehow linked together, and entanglement method provides a 
reliable settlement between strong robustness, security, pragmatism, and efficiency. 
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CONCLUSIONS 
The burden of healthcare costs will continue to grow unless and until the efficiency and 
efficacy of healthcare systems will be accomplished. It is critical that policymakers take 
action to restrain the rising costs of healthcare today. Obviously, we have to bear in mind 
that the general aim is a continued public health improvement that will also help eliminate 
health gaps, as the relative position of vulnerable population groups gets better. HDE and 
AI-based analyses can be adopted to improve the effectiveness of health governance 
systems in ways that also lead to better quality of care.  
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FIGURES AND TABLES 
 
Tables 
Table 1 - Relevant limits of health data [15, 16] 
Domain Issue 
Diagnosis 
Diagnostic procedures that have not the 
recommended validation of medical associations 
Limited diagnostic information for a proper 
patient inclusion 
Healthcare needs  
Identification of appropriate funding 
Completeness 
Restrictions on access to drugs 
Intermediate outcomes 
Real measure of effectiveness 
Treatments delivered outside the considered 
system 
Health system structure 
Insurance coverage 
Referral patterns 
Risk factors 
Genetic susceptibility  
(genetic predisposition to diseases) 
Lifestyle habits and behavioural factors 
Environmental influences 
Accuracy 
Coding (i.e. classification of diseases) 
Subpopulation 
Sample size 
Costs 
Direct costs are not systematically gathered 
Management costs due to side effects are often 
not accounted for 
Indirect and social costs are sporadically 
collected 
25 
 
Costing data to perform a complete budget 
impact assessment are often missing 
Timeframe Period of data collection 
 Different follow-ups 
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Table 2 - The HDE outputs and solutions 
Cluster Output 
Actual economic and 
clinical assessment 
Multi-value based assessment of health 
interventions 
Health technology assessment 
Healthcare needs  
Identification of appropriate funding 
Predictive simulators 
Budget impact models 
Spending predictor models 
Disease models 
Epidemiological models 
Self-learning data 
analyses 
Computational profiling of national and regional 
health expenses 
Predictive behavioural prescriptive analysis 
Predictive treatment approach analysis 
Genetic-genomic profiling of disease risk and 
management (genomics) 
Health governance 
models 
Comprehensive effects of current and future 
health policy decisions including demographic 
dynamics of population (ageing) 
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Figures 
 
 
 
Figure 1 - Determinants of healthcare spending. Modified from the version by De La 
Maisonneuve et al. [4]. 
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Figure 2 - Unbalanced power relationship between GDP contributors and economic 
resources absorbed by healthcare demand. 
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Figure 3 - Source of data entangled in the HDE. 
HTA - Health Technology Assessment; Wellderly - Wellness of elderly people 
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Figure 4 - Self-learning cycle of artificial intelligence. MC = Monte Carlo simulation. AIXI 
= artificial intelligence agent. Modified from Veness J. et al. [21]. 
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